Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study,The Lancet Child & Adolescent Health

当前位置： X-MOL 学术 › Lancet Child Adolesc. Health › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study
The Lancet Child & Adolescent Health ( IF 19.9 ) Pub Date : 2024-08-30 , DOI: 10.1016/s2352-4642(24)00167-6
Justine Kahn ₁ , Ruta Brazauskas ₂ , Stephanie Bo-Subait ₃ , David Buchbinder ₄ , Betty K Hamilton ₅ , Hélène Schoemans ₆ , Allistair A Abraham ₇ , Vaibhav Agrawal ₈ , Jeffery J Auletta ₉ , Sherif M Badawy ₁₀ , Amer Beitinjaneh ₁₁ , Neel S Bhatt ₁₂ , Larisa Broglie ₁₃ , Miguel Angel Diaz Perez ₁₄ , Nosha Farhadfar ₁₅ , Cesar O Freytes ₁₆ , Robert Peter Gale ₁₇ , Siddhartha Ganguly ₁₈ , Robert J Hayashi ₁₉ , Peiman Hematti ₂₀ , Gerhard C Hildebrandt ₂₁ , Yoshihiro Inamoto ₂₂ , Rammurti T Kamble ₂₃ , Jane Koo ₂₄ , Hillard M Lazarus ₂₅ , Samantha J Mayo ₂₆ , Parinda A Mehta ₂₄ , Kasiani C Myers ₂₄ , Taiga Nishihori ₂₇ , Tim Prestidge ₂₈ , Seth J Rotz ₂₉ , Bipin N Savani ₃₀ , Raquel M Schears ₃₁ , Akshay Sharma ₃₂ , Elizabeth Stenger ₃₃ , Celalettin Ustun ₃₄ , Kirsten M Williams ₃₃ , Lynda M Vrooman ₃₅ , Prakash Satwani ₁ , Rachel Phelan ₁₃

Affiliation

Department of Pediatrics, Columbia University Medical Center, New York, NY, USA.
Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA.
Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA.
Division of Pediatric Hematology, Children's Hospital of Orange County, Orange, CA, USA.
Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Department of Hematology, UZ Leuven, Leuven, Belgium; Academic Centre for Nursing and Midwifery, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Division of Blood and Marrow Transplantation, Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA.
Hematology/Oncology/BMT Clinic and Infectious Diseases Clinic, Nationwide Children's Hospital, Columbus, OH, USA.
Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Division of Hematology, Oncology, and Stem Cell Transplantation, Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Division of Transplantation and Cellular Therapy, Department of Medicine, University of Miami, Miami, FL, USA; Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics, Miami, FL, USA.
Division of Hematology/Oncology and Bone Marrow Transplant, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA; Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain.
Division of Hematology/Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, FL, USA.
University of Texas Health Science Center San Antonio, San Antonio, TX, USA.
Centre for Haematology, Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, London, UK.
Houston Methodist Neal Cancer Center, Houston, TX, USA.
Division of Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
BMT and Cellular Therapy Program, Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA; Division of Hematology, Oncology and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
University of Missouri, Ellis Fischel Cancer Center, Columbia, MO, USA.
Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Center for Cell and Gene Therapy, Baylor College of Medicine and Houston Methodist Hospital, Houston, TX, USA.
Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Lawrence S Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Blood and Marrow Transplant and Cellular Immunotherapy Program, Moffitt Cancer Center, Tampa, FL, USA; Department of Oncologic Sciences, Morsani College of Medicine, University South of Florida, Tampa, FL, USA.
Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand.
Department of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, OH, USA.
Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Emergency Medicine, University of Central Florida, Orlando, FL, USA.
Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA.
Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA.
Division of Hematology, Oncology and Cell Therapy, Rush University, Chicago, IL, USA.
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Continued advances in haematopoietic cell transplantation (HCT) for children with non-malignant diseases (NMDs) have led to a growing population of survivors in whom late occurring toxic effects remain a challenge. We investigated the incidence of and risk factors for post-transplant toxicities in a contemporary cohort of children and adolescents undergoing HCT for NMDs.

中文翻译：